Inventor · disambiguated record
Peter Orth
Also filed as: ORTH PETER · ORTH PETER M R
26 granted patents·4 pending applications·243 citations·filing 2003–2017
96Inventor score
Top patents by PatentIndex Score
30 records- 0196US7807160B2Engineered anti-IL-23 antibodiesSCHERING CORP·Filed 2006·Granted Oct 5, 2010·65 cites·4 claims
- 0295US7488745B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2007·Granted Feb 10, 2009·23 cites·34 claims
- 0392US7504424B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2006·Granted Mar 17, 2009·24 cites·3 claims
- 0491US7482370B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Jan 27, 2009·20 cites·79 claims
- 0588US8207219B2Ion channel modulating activity IFEDIDA DAVID·Filed 2010·Granted Jun 26, 2012·14 cites·10 claims
- 0688US7879890B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Feb 1, 2011·6 cites·11 claims
- 0787US9181632B1C.difficile toxin B CROP domain peptides, antibodies and complexes thereofMERCK SHARP & DOHME·Filed 2014·Granted Nov 10, 2015·12 cites·4 claims
- 0886US7687527B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Mar 30, 2010·8 cites·9 claims
- 0986US7674820B2Ion channel modulating activity ICARDIOME PHARMA CORP·Filed 2004·Granted Mar 9, 2010·23 cites·8 claims
- 1084US7683085B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Mar 23, 2010·6 cites·10 claims
- 1183US9803010B2Crystalline anti-human IL-23p19 antibodiesMERCK SHARP & DOHME·Filed 2013·Granted Oct 31, 2017·5 cites·8 claims
- 1283US7507545B2Ion channel modulating activity methodCARDIOME PHARMA CORP·Filed 2004·Granted Mar 24, 2009·12 cites·1 claims
- 1382US7652020B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Jan 26, 2010·5 cites·48 claims
- 1480US8513389B2Engineered anti-IL-23p19 antibodiesPRESTA LEONARD G·Filed 2012·Granted Aug 20, 2013·4 cites·7 claims
- 1580US7529628B2Methods for identifying modified tumor necrosis factor-alpha converting enzyme inhibitorsSCHERING CORP·Filed 2006·Granted May 5, 2009·2 cites·4 claims
- 1679US7138264B1Modified tumor necrosis factor-alpha converting enzyme and methods of use thereofSCHERING CORP·Filed 2003·Granted Nov 21, 2006·3 cites·11 claims
- 1776US8759357B2Inhibitors of fatty acid binding protein (FABP)SHIPPS JR GERALD W·Filed 2010·Granted Jun 24, 2014·6 cites·8 claims
- 1875US7824897B2Modified tumor necrosis factor-alpha converting enzyme and methods of use thereofSCHERING CORP·Filed 2010·Granted Nov 2, 2010·1 cites·6 claims
- 1971US8815875B2Inhibitors of fatty acid binding protein (FABP)SHIPPS JR GERALD W·Filed 2009·Granted Aug 26, 2014·2 cites·11 claims
- 2070US7700753B2Modified tumor necrosis factor-alpha converting enzyme and methods of use thereofSCHERING CORP·Filed 2009·Granted Apr 20, 2010·0 cites·8 claims
- 2163US8889683B2Substituted quinoxalines as inhibitors of fatty acid binding proteinCHENG CLIFFORD·Filed 2011·Granted Nov 18, 2014·2 cites·9 claims
- 2263US2009270478A1Ion channel modulating activity iiCARDIOME PHARMA CORP·Filed 2009·Application pending·0 cites
- 2362US8679472B1Crystal of human interferon alpha 2B in complex with zincREICHERT PAUL·Filed 2007·Granted Mar 25, 2014·0 cites·12 claims
- 2460US7285408B2Crystalline form of an n231 mutant catalytic domain of ADAM33 and methods of use thereofSCHERING CORP·Filed 2003·Granted Oct 23, 2007·0 cites·8 claims
- 2558US9809648B2Engineered anti-IL-23p19 antibodiesMERCK SHARP & DOHME·Filed 2012·Granted Nov 7, 2017·0 cites·12 claims
- 2656US2010111966A1Engineered anti-il-23p19 antibodiesSCHERING CORP·Filed 2008·Application pending·0 cites
- 2749US2011002942A1Engineered Anti-IL-23 AntibodiesSCHERING CORP·Filed 2010·Application pending·0 cites
- 2846US11014920B2Factor XIIa inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted May 25, 2021·0 cites·14 claims
- 2940US10875851B2Factor XIIa inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Dec 29, 2020·0 cites·13 claims
- 3035US2012095073A1Ion channel modulating activity iiFEDIDA DAVID·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Orth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →